keyword
https://read.qxmd.com/read/38649466/-update-kidney-allograft-pathology-a%C3%A2-better-depiction-of-microvascular-inflammation
#21
REVIEW
Nicolas Kozakowski
BACKGROUND: The Banff Foundation produces recommendations for classifying various lesions in renal allografts. Experts gather to update the classification every other year based on new scientific and clinical evidence. OBJECTIVES: This article presents the most important changes incorporated into the new recommendations after the last Banff conference. MATERIALS AND METHODS: The author of this article personally took part in the Banff conference and the subsequent survey, reported on the activities of a Banff working group (peritubular capillaritis) on-site, and contributed to drafting the recently published meeting report...
April 22, 2024: Pathologie (Heidelb)
https://read.qxmd.com/read/38643544/zhen-wu-tang-ameliorates-lupus-nephritis-by-diminishing-renal-tissue-resident-memory-cd8-t-cells-via-suppressing-il-15-stat3-pathway
#22
JOURNAL ARTICLE
Chun-Ling Liang, Yu-Yan Wei, Yi Chen, Yini Luo, Fenglian Qin, Yuchao Chen, Huazhen Liu, Feifei Qiu, Junbiao Wu, Bin Yang, Yuntao Liu, Zhenhua Dai
Zhen-Wu-Tang (ZWT), a conventional herbal mixture, has been recommended for treating lupus nephritis (LN) in clinic. However, its mechanisms of action remain unknown. Here we aimed to define the immunological mechanisms underlying the effects of ZWT on LN and to determine whether it affects renal tissue-resident memory T (TRM ) cells. Murine LN was induced by a single injection of pristane, while in vitro TRM cells differentiated with IL-15/TGF-β. We found that ZWT or mycophenolate mofetil treatment significantly ameliorated kidney injury in LN mice by decreasing 24-h urine protein, Scr and anti-dsDNA Ab...
April 20, 2024: Biomedicine & Pharmacotherapy
https://read.qxmd.com/read/38642328/lupus-exacerbation-in-ovalbumin-induced-asthma-in-fc-gamma-receptor-iib-deficient-mice-partly-due-to-hyperfunction-of-dendritic-cells
#23
JOURNAL ARTICLE
Thansita Bhunyakarnjanarat, Jiradej Makjaroen, Wilasinee Saisorn, Kankorn Hirunsap, Jidapond Chiewchengchol, Patcharee Ritprajak, Asada Leelahavanichkul
BACKGROUND: Although allergy might be another factor that exacerbates lupus as demonstrated by several epidemiologic studies, the direct correlation between lupus activities and allergy is still in question. OBJECTIVE: To explore the correlation between allergic reaction and lupus activities. METHODS: The allergic asthma model using ovalbumin (OVA) administration in wildtype (WT) and Fc gamma receptor IIb deficient (FcgRIIb-/-) mice (a lupus-prone model) together with in vitro experiments on bone marrow-derived dendritic cells (DCs) were performed...
April 20, 2024: Asian Pacific Journal of Allergy and Immunology
https://read.qxmd.com/read/38642109/a-phase-i-trial-of-autologous-rak-cell-immunotherapy-in-metastatic-renal-cell-carcinoma
#24
JOURNAL ARTICLE
Jing Xu, Wen Zhang, Jinlian Tong, Caixia Liu, Qiaohui Zhang, Liren Cao, Jiangyong Yu, Aiping Zhou, Jie Ma
BACKGROUND: Treatment of metastatic renal cell carcinoma (mRCC) remains a challenge worldwide. Here, we introduced a phase I trial of autologous RAK cell therapy in patients with mRCC whose cancers progressed after prior systemic therapy. Although RAK cells have been used in clinic for many years, there has been no dose-escalation study to demonstrate its safety and efficacy. METHODS: We conducted a phase I trial with a 3 + 3 dose-escalation design to investigate the dose-related safety and efficacy of RAK cells in patients with mRCC whose cancers have failed to response to systemic therapy (ChiCTR1900021334)...
April 20, 2024: Cancer Immunology, Immunotherapy: CII
https://read.qxmd.com/read/38641147/borderline-rejection-to-treat-or-not-to-treat
#25
JOURNAL ARTICLE
Alessandra Palmisano, Marta D'Angelo, Ilaria Gandolfini, Marco Delsante, Giovanni Maria Rossi, Micaela Gentile, Enrico Fiaccadori, Paolo Cravedi, Umberto Maggiore
INTRODUCTION: It is unclear whether kidney transplant recipients with a biopsy diagnosis as a "borderline" acute T-cell mediated rejection (TCMR) requires the treatment with intravenous (iv) steroids pulse plus/minus intensification of the maintenance therapy (TRT) in comparison with the simple clinical follow-up (F-UP). METHODS: We retrospectively followed a consecutive series of kidney transplant recipients diagnosed with a borderline acute TCMR at biopsy by surveillance or clinical indication for 12 months and compared TRT and F-UP groups...
April 17, 2024: Transplant Immunology
https://read.qxmd.com/read/38639584/the-nlrp3-inflammasome-is-a-major-cause-of-acute-renal-failure-induced-by-polypeptide-antibiotics
#26
JOURNAL ARTICLE
Tomohiro Kagi, Aya Inoue, Takuya Noguchi, Wakana Suzuki, Saya Takano, Kohei Otani, Rio Naganuma, Yuto Sekiguchi, Yusuke Hirata, Sawako Shindo, Gi-Wook Hwang, Atsushi Matsuzawa
Drug-induced acute renal failure (ARF) is a public health concern that hinders optimal drug therapy. However, pathological mechanisms of drug-induced ARF remain to be elucidated. Here, we show that a pathological process of drug-induced ARF is mediated by proinflammatory cross-talk between kidney tubular cells and macrophages. Both polymyxin B and colistin, polypeptide antibiotics, frequently cause ARF, stimulated the ERK and NF-κB pathways in kidney tubular cells, and thereby upregulated M-CSF and MCP-1, leading to infiltration of macrophages into the kidneys...
April 19, 2024: Journal of Immunology
https://read.qxmd.com/read/38633264/-nlrp2-deletion-ameliorates-kidney-damage-in-a-mouse-model-of-cystinosis
#27
JOURNAL ARTICLE
Marianna Nicoletta Rossi, Valentina Matteo, Francesca Diomedi-Camassei, Ester De Leo, Olivier Devuyst, Mohamed Lamkanfi, Ivan Caiello, Elena Loricchio, Francesco Bellomo, Anna Taranta, Francesco Emma, Fabrizio De Benedetti, Giusi Prencipe
Cystinosis is a rare autosomal recessive disorder caused by mutations in the CTNS gene that encodes cystinosin, a ubiquitous lysosomal cystine/H+ antiporter. The hallmark of the disease is progressive accumulation of cystine and cystine crystals in virtually all tissues. At the kidney level, human cystinosis is characterized by the development of renal Fanconi syndrome and progressive glomerular and interstitial damage leading to end-stage kidney disease in the second or third decade of life. The exact molecular mechanisms involved in the pathogenesis of renal disease in cystinosis are incompletely elucidated...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38633257/development-of-a-nomogram-for-membranous-nephropathy-prediction-in-patients-with-primary-sj%C3%A3-gren-s-syndrome-a-6-year-retrospective-study
#28
JOURNAL ARTICLE
Lihui Guo, Shan Zhao, Xudong Liu
OBJECTIVES: Nephritis is a life-threatening complication of primary Sjögren's syndrome (pSS), with membranous nephropathy (MN) being prevalent. Renal biopsy is the gold standard for MN diagnosis, but it is invasive and cannot be repeatedly performed. This study aimed to develop a nomogram for the prediction of MN in patients with pSS. METHODS: This retrospective study included patients with pSS admitted to the Rheumatology and Immunology Department of the First Affiliated Hospital of China Medical University between January 2015 and January 2021...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38629076/a-novel-flow-cytometry-panel-to-identify-prognostic-markers-for-steroid-sensitive-forms-of-idiopathic-nephrotic-syndrome-in-childhood
#29
JOURNAL ARTICLE
Martina Riganati, Federica Zotta, Annalisa Candino, Ester Conversano, Antonio Gargiulo, Marco Scarsella, Anna Lo Russo, Chiara Bettini, Francesco Emma, Marina Vivarelli, Manuela Colucci
INTRODUCTION: The clinical evolution of steroid-sensitive forms of pediatric idiopathic nephrotic syndrome (INS) is highly heterogeneous following the standard treatment with prednisone. To date, no prognostic marker has been identified to predict the severity of the disease course starting from the first episode. METHODS: In this monocentric prospective cohort study we set up a reproducible and standardized flow cytometry panel using two sample tubes (one for B-cell and one for T-cell subsets) to extensively characterized the lymphocyte repertoire of INS pediatric patients...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38627024/systematic-review-of-the-efficacy-and-safety-of-lenvatinib-in-various-solid-tumors
#30
REVIEW
Shuai Geng, Tong Liu, Nan Wang, Xinyue Gao, Xinyu Luo, Ning Shi, Shuai Jiang
Objective The purpose of this study was to investigate the efficacy and safety of lenvatinib in various types of solid tumors. Method By searching PubMed, Web of Science, Cochrane, CNKI, Wanfang and other databases, all the literatures about the comparison of clinical efficacy of lenvatinib in the treatment of various solid tumors. According to the criteria of inclusion and exclusion of literature, two participants screened the literature, collated the data and evaluated the literature. RevMan 5.4 software was used for meta-analysis of the included literatures...
April 16, 2024: Immunopharmacology and Immunotoxicology
https://read.qxmd.com/read/38626544/dipeptidase-1-promotes-ferroptosis-in-renal-tubular-epithelial-cells-in-diabetic-nephropathy-via-inhibition-of-the-gsh-gpx4-axis
#31
JOURNAL ARTICLE
Yan Li, Xueqi Wang, Qidong Zhang, Dongli Tian, Yu Bai, Yiduo Feng, Wenhu Liu, Zongli Diao
Renal tubular injury is an important pathological change associated with diabetic nephropathy (DN), in which ferroptosis of renal tubular epithelial cells is critical to its pathogenesis. Inhibition of the glutathione/glutathione peroxidase 4 (GSH/GPX4) axis is the most important mechanism in DN tubular epithelial cell ferroptosis, but the underlying reason for this is unclear. Our biogenic analysis showed that a zinc-dependent metalloproteinase, dipeptidase 1 (DPEP1), is associated with DN ferroptosis. Here, we investigated the role and mechanism of DPEP1 in DN tubular epithelial cell ferroptosis...
April 15, 2024: International Immunopharmacology
https://read.qxmd.com/read/38623626/mass-cytometry-reveals-atypical-immune-profile-notably-impaired-maturation-of-memory-cd4-t-with-gb3-related-cd27-expression-in-cd4-t-cells-in-fabry-disease
#32
JOURNAL ARTICLE
Wladimir Mauhin, Gaelle Dzangue-Tchoupou, Damien Amelin, Aurélien Corneau, Foudil Lamari, Yves Allenbach, Bertrand Dussol, Vanessa Leguy-Seguin, Pauline D'Halluin, Marie Matignon, François Maillot, Kim-Heang Ly, Gérard Besson, Marjolaine Willems, Fabien Labombarda, Agathe Masseau, Christian Lavigne, Didier Lacombe, Hélène Maillard, Olivier Lidove, Olivier Benveniste
Fabry disease (FD) is an X-linked disease characterized by an accumulation of glycosphingolipids, notably of globotriaosylceramide (Gb3) and globotriaosylsphingosine (lysoGb3) leading to renal failure, cardiomyopathy, and cerebral strokes. Inflammatory processes are involved in the pathophysiology. We investigated the immunological phenotype of peripheral blood mononuclear cells in Fabry patients depending on the clinical phenotype, treatment, Gb3, and lysoGb3 levels and the presence of anti-drug antibodies (ADA)...
April 16, 2024: Journal of Inherited Metabolic Disease
https://read.qxmd.com/read/38622070/the-unique-interplay-between-antinuclear-antibodies-and-nuclear-molecules-in-the-pathogenesis-of-sle
#33
REVIEW
David S Pisetsky
Systemic lupus erythematosus (SLE) is a prototypic autoimmune disease that primarily affects young women and causes a wide range of inflammatory manifestations. The hallmark of SLE is the production of antibodies to components of the cell nucleus (antinuclear antibodies or ANAs). These antibodies can bind to DNA, RNA and protein complexes with nucleic acids. Among ANAs, antibodies to DNA (anti-DNA) are markers for classification and disease activity, waxing and waning in many patients. In the blood, anti-DNA antibodies can bind DNA to form immune complexes with two distinct roles in pathogenesis: renal deposition to provoke nephritis and stimulation of cytokine production following uptake into innate immune cells and interaction with internal nucleic acid sensors...
April 15, 2024: Arthritis & Rheumatology
https://read.qxmd.com/read/38616569/kidney-after-liver-transplantation-does-not-have-an-increased-risk-of-rejection-compared-to-liver-alone
#34
JOURNAL ARTICLE
Peter Ghali, Ramez M Ibrahim, David Hodge, Launia White, Hani M Wadei
BACKGROUND: Simultaneous liver kidney (SLK) transplant protects against acute cellular rejection. In 2017, UNOS implemented a "safety net" policy to allow patients with renal recovery to avoid renal transplantation. Whether kidney after liver transplantation (KALT) increases the risk of rejection is unknown. METHODS: We performed a retrospective analysis of the Organ Procurement and Transplantation Network (OPTN) database of adult patients who received liver transplant, SLK or KALT between 2010 and 2020...
April 2024: Clinical Transplantation
https://read.qxmd.com/read/38615268/the-burden-of-hcv-among-prevalent-hemodialysis-patients-after-the-national-egyptian-hcv-eradication-program
#35
MULTICENTER STUDY
Iman I Sarhan, Magdy M ELSharkawy, Maha M El Gaafary, Doaa M T Hendam, Khaled Gouda
In the first phase of its treatment program, Egypt aimed to treat 250,000 people annually until 2020, thereby reducing the number of viremic patients and limiting hepatitis C virus (HCV) transmission. Egypt strives to eradicate HCV and HCV-associated morbidity by 2030. This study aimed to determine the prevalence of HCV infection among end-stage renal disease patients and the reasons for non-treatment among those offered free medication. This multi-center cross-sectional study was conducted during the period from November 2022 to April 2023...
April 2024: Egyptian Journal of Immunology
https://read.qxmd.com/read/38612943/boosting-clear-cell-renal-carcinoma-specific-drug-discovery-using-a-deep-learning-algorithm-and-single-cell-analysis
#36
JOURNAL ARTICLE
Yishu Wang, Xiaomin Chen, Ningjun Tang, Mengyao Guo, Dongmei Ai
Clear cell renal carcinoma (ccRCC), the most common subtype of renal cell carcinoma, has the high heterogeneity of a highly complex tumor microenvironment. Existing clinical intervention strategies, such as target therapy and immunotherapy, have failed to achieve good therapeutic effects. In this article, single-cell transcriptome sequencing (scRNA-seq) data from six patients downloaded from the GEO database were adopted to describe the tumor microenvironment (TME) of ccRCC, including its T cells, tumor-associated macrophages (TAMs), endothelial cells (ECs), and cancer-associated fibroblasts (CAFs)...
April 8, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38609390/semmaphorin-3%C3%A2-a-causes-immune-suppression-by-inducing-cytoskeletal-paralysis-in-tumour-specific-cd8-t-cells
#37
JOURNAL ARTICLE
Mike B Barnkob, Yale S Michaels, Violaine André, Philip S Macklin, Uzi Gileadi, Salvatore Valvo, Margarida Rei, Corinna Kulicke, Ji-Li Chen, Vitul Jain, Victoria K Woodcock, Huw Colin-York, Andreas V Hadjinicolaou, Youxin Kong, Viveka Mayya, Julie M Mazet, Gracie-Jennah Mead, Joshua A Bull, Pramila Rijal, Christopher W Pugh, Alain R Townsend, Audrey Gérard, Lars R Olsen, Marco Fritzsche, Tudor A Fulga, Michael L Dustin, E Yvonne Jones, Vincenzo Cerundolo
Semaphorin-3A (SEMA3A) functions as a chemorepulsive signal during development and can affect T cells by altering their filamentous actin (F-actin) cytoskeleton. The exact extent of these effects on tumour-specific T cells are not completely understood. Here we demonstrate that Neuropilin-1 (NRP1) and Plexin-A1 and Plexin-A4 are upregulated on stimulated CD8+ T cells, allowing tumour-derived SEMA3A to inhibit T cell migration and assembly of the immunological synapse. Deletion of NRP1 in both CD4+ and CD8+ T cells enhance CD8+ T-cell infiltration into tumours and restricted tumour growth in animal models...
April 12, 2024: Nature Communications
https://read.qxmd.com/read/38608995/porto-sinusoidal-vascular-disorder-and-nephrotic-range-proteinuria-due-to-venous-vasculitis-in-beh%C3%A3-et-s-disease
#38
JOURNAL ARTICLE
M E Annink, T B van der Houwen, J J T H Roelofs, R B Takkenberg, J A M van Laar, N C van der Weerd, A E Hak, A J Kwakernaak
Behçet's disease (BD) is an autoinflammatory disease of multifactorial and polygenic etiology, potentially involving arteries and veins of any size resulting in variable vessel vasculitis. We report a case of an Iranian male that presented with porto-sinusoidal vascular disorder due to venous vasculitis as initial manifestation of BD. Despite immunosuppression and anticoagulation, he subsequently developed severe nephrotic-range proteinuria that mimicked a primary renal disease but was completely and immediately ameliorated by stenting of the vena cava...
April 10, 2024: Clinical Immunology: the Official Journal of the Clinical Immunology Society
https://read.qxmd.com/read/38608473/the-sp1-sirt1-acly-signaling-axis-mediates-fatty-acid-oxidation-in-renal-ischemia-reperfusion-induced-renal-fibrosis
#39
JOURNAL ARTICLE
Huailiang Wu, Liyan Wang, Peng Kang, Xiangjun Zhou, Wei Li, Zhongyuan Xia
BACKGROUND: Renal ischemia-reperfusion is the primary cause of acute kidney injury (AKI). Clinically, most patients who experience ischemia-reperfusion injury eventually progress gradually to renal fibrosis and chronic kidney disease (CKD). However, the underlying mechanism for AKI to CKD transition remain absent. Our study demonstrated that the downregulation of sirtuin 1 (Sirt1)-mediated fatty acid oxidation (FAO) facilitates IRI-induced renal fibrosis. METHODS: The IRI animal model was established, and ribonucleic acid (RNA) sequencing was used to explore potential differentially expressed genes (DEGs) and pathways...
April 11, 2024: International Immunopharmacology
https://read.qxmd.com/read/38607586/dual-loss-of-pbrm1-and-rad51-identifies-hyper-sensitive-subset-patients-to-immunotherapy-in-clear-cell-renal-cell-carcinoma
#40
JOURNAL ARTICLE
Ziyang Xu, Wenbin Jiang, Li Liu, Youqi Qiu, Jiahao Wang, Siyuan Dai, Jianming Guo, Jiejie Xu
BACKGROUND: Homologous recombination deficiency (HRD), though largely uncharacterized in clear cell renal cell carcinoma (ccRCC), was found associated with RAD51 loss of expression. PBRM1 is the second most common mutated genes in ccRCC. Here, we introduce a HRD function-based PBRM1-RAD51 ccRCC classification endowed with diverse immune checkpoint blockade (ICB) responses. METHODS: Totally 1542 patients from four independent cohorts were enrolled, including our localized Zhongshan hospital (ZSHS) cohort and Zhongshan hospital metastatic RCC (ZSHS-mRCC) cohort, The Cancer Genome Atlas (TCGA) cohort and CheckMate cohort...
April 12, 2024: Cancer Immunology, Immunotherapy: CII
keyword
keyword
109132
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.